Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1989 2
1990 1
1992 1
1994 1
1995 1
1996 1
1998 2
2000 1
2001 3
2004 2
2005 1
2011 1
2013 2
2014 2
2015 5
2016 5
2017 3
2018 5
2019 4
2020 5
2021 4
2022 1
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Emerging trabecular outflow drugs.
Kopczynski CC, Epstein DL. Kopczynski CC, et al. J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):85-7. doi: 10.1089/jop.2013.0197. Epub 2013 Dec 4. J Ocul Pharmacol Ther. 2014. PMID: 24304197 Free PMC article. No abstract available.
Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET).
Araie M, Sugiyama K, Aso K, Kanemoto K, Iwata R, Hollander DA, Senchyna M, Kopczynski CC. Araie M, et al. Among authors: kopczynski cc. Adv Ther. 2023 Oct;40(10):4639-4656. doi: 10.1007/s12325-023-02550-w. Epub 2023 Aug 21. Adv Ther. 2023. PMID: 37603205 Free PMC article. Clinical Trial.
Consensus recommendations for trabecular meshwork cell isolation, characterization and culture.
Keller KE, Bhattacharya SK, Borrás T, Brunner TM, Chansangpetch S, Clark AF, Dismuke WM, Du Y, Elliott MH, Ethier CR, Faralli JA, Freddo TF, Fuchshofer R, Giovingo M, Gong H, Gonzalez P, Huang A, Johnstone MA, Kaufman PL, Kelley MJ, Knepper PA, Kopczynski CC, Kuchtey JG, Kuchtey RW, Kuehn MH, Lieberman RL, Lin SC, Liton P, Liu Y, Lütjen-Drecoll E, Mao W, Masis-Solano M, McDonnell F, McDowell CM, Overby DR, Pattabiraman PP, Raghunathan VK, Rao PV, Rhee DJ, Chowdhury UR, Russell P, Samples JR, Schwartz D, Stubbs EB, Tamm ER, Tan JC, Toris CB, Torrejon KY, Vranka JA, Wirtz MK, Yorio T, Zhang J, Zode GS, Fautsch MP, Peters DM, Acott TS, Stamer WD. Keller KE, et al. Among authors: kopczynski cc. Exp Eye Res. 2018 Jun;171:164-173. doi: 10.1016/j.exer.2018.03.001. Epub 2018 Mar 9. Exp Eye Res. 2018. PMID: 29526795 Free PMC article. Review.
Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid Conjugates.
Sturdivant J, Williams SS, Ina M, Weksler M, McDougal A, Clancy D, deLong MA, Girouard N, Zaretskaia M, Brennan K, Glendenning A, Foley B, Lin CW, White JC, Kopczynski C, Kelly CR. Sturdivant J, et al. Among authors: kopczynski c. J Ocul Pharmacol Ther. 2023 Mar;39(2):117-127. doi: 10.1089/jop.2022.0129. Epub 2023 Jan 4. J Ocul Pharmacol Ther. 2023. PMID: 36602977
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility.
Gordhan HM, Miller ST, Clancy DC, Ina M, McDougal AV, Cutno DK, Brown RV, Lichorowic CL, Sturdivant JM, Vick KA, Williams SS, deLong MA, White JC, Kopczynski CC, Ellis DA. Gordhan HM, et al. Among authors: kopczynski cc. J Med Chem. 2023 Jul 13;66(13):8929-8950. doi: 10.1021/acs.jmedchem.3c00519. Epub 2023 Jun 14. J Med Chem. 2023. PMID: 37314941
52 results